SCHEMBL6948732

SCHEMBL6948732

COc1cc(N)c(C#N)c(OC2CCC2)c1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.36
KDM4E B2RXH2 4/20 0.36
HPGD P15428 3/20 0.36
GBA1 P04062 1/20 0.36
PDE4B Q07343 4/20 0.35
MAPKAPK2 P49137 3/20 0.35
PDE4A P27815 4/20 0.34
PDE4C Q08493 3/20 0.34
PDE4D Q08499 3/20 0.34
CYP1A2 P05177 1/20 0.34
CYP3A4 P08684 1/20 0.34
CYP2C19 P33261 1/20 0.34
ADORA2A P29274 1/20 0.34
ADORA2B P29275 1/20 0.34
ADORA1 P30542 1/20 0.34
PDE5A O76074 1/20 0.34
PDE1A P54750 1/20 0.34
PDE1B Q01064 1/20 0.34
PDE1C Q14123 1/20 0.34
HSD17B10 Q99714 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5776479 0.83 PDE4B (0.35) ALDH1A1KDM4EHPGDGBA1PDE4B
SCHEMBL15647191 0.80 ALDH1A1 (0.46) ALDH1A1KDM4EHPGDGBA1PDE4B
SCHEMBL6953358 0.77 KDM4E (0.40) ALDH1A1KDM4EHPGDPDE4BMAPKAPK2
SCHEMBL5774696 0.77 IKBKB (0.41) ALDH1A1KDM4EHPGDMAPKAPK2ADORA2A
SCHEMBL7653423 0.74 KMT2A (0.43) ALDH1A1KDM4EPDE4BMAPKAPK2PDE4A
SCHEMBL2418439 0.73 MCHR1 (0.42) ALDH1A1KDM4EHPGDPDE5APDE1A
SCHEMBL5778419 0.73 MAPKAPK2 (0.40) ALDH1A1KDM4EHPGDGBA1MAPKAPK2
SCHEMBL5776551 0.72 IKBKB (0.40) ALDH1A1KDM4EHPGDMAPKAPK2ADORA2A
SCHEMBL21474536 0.72 ERBB2 (0.38) ALDH1A1KDM4EHPGDGBA1ADORA2A
SCHEMBL27368676 0.71 ALDH1A1 (0.58) ALDH1A1PDE4BPDE4APDE4CPDE4D

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0887344-B1 Quinolines and quinazolines useful in therapy PFIZER LTD (GB) 2003-12-03 EP disclosed
US-6417194-B1 TREATMENT OF BENIGN PROSTATIC HYPERPLASIA PFIZER, INC. 2002-07-09 US disclosed
US-6048864-A Quinolines and quinazolines useful in therapy PFIZER INC (US) 2000-04-11 US disclosed
EP-0887344-A1 Quinolines and quinazolines useful in therapy Pfizer Limited (GB) 1998-12-30 EP disclosed